Tamsulosin Hydrochloride Capsule
Product Images NDC 68071-1840

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68071-1840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 1840 1)

Label for Tamsulosin Hydrochloride 0.4 mg capsules by NuCare Pharmaceuticals, Inc. The label indicates a 100-count package with NDC 68071-1840-1. It includes storage instructions to keep at controlled temperature 59-86°F and a warning to keep out of reach of children. Manufacturer information lists Himmachal Pharmaceuticals Ltd., Macleods Pradesh, India. The label also references prescription-only status and contains barcode and serialization elements.*

FDA Label Image

Fig (Tamsulosin Fig 1)

A line graph showing plasma concentration (ng/mL) over time (hours) comparing fed and fasted conditions. The plasma concentration rises sharply to a peak around 4 hours for the fasted state and more gradually to a lower peak in the fed state, then declines over 36 hours.*

FDA Label Image

Fig (Tamsulosin Fig 2a)

A line graph showing mean change over duration of treatment in weeks, comparing three treatment groups: 0.8 mg, 0.4 mg, and placebo. The x-axis represents treatment duration from baseline to 13 weeks, and the y-axis shows mean change. The 0.8 mg and 0.4 mg groups show decreasing mean change over time, while placebo remains relatively stable.*

FDA Label Image

Fig (Tamsulosin Fig 2b)

A line graph showing the mean change over a 13-week treatment duration for Tamsulosin Hydrochloride capsules in two doses (0.8 mg and 0.4 mg) compared to placebo. The x-axis represents treatment duration in weeks, and the y-axis shows mean change values. The graph includes sample sizes at various weeks and indicates mean change trends for each treatment group.*

FDA Label Image

Fig (Tamsulosin Fig 3a)

A line graph showing mean change in a measured variable (mL/sec) over the duration of treatment in weeks. Three groups are compared: 0.8 mg dose, 0.4 mg dose, and placebo. The graph illustrates changes from baseline to 13 weeks, with the 0.8 mg and 0.4 mg doses showing higher mean change compared to placebo over time.*

FDA Label Image

Fig (Tamsulosin Fig 3b)

A line graph depicting mean change over treatment duration in weeks, comparing three groups: 0.8 mg, 0.4 mg, and placebo. The y-axis shows mean change in mL/sec, and the x-axis shows weeks of treatment up to 20 weeks, including last observation carried forward (LOCF) data. Each treatment group is represented by different markers and dashed or solid lines.*

FDA Label Image

Str (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride showing its molecular connectivity with hydrochloride indicated as a separate component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.